{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T18:55:04Z","timestamp":1790621704918,"version":"4.1.0"},"reference-count":68,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2016,7,1]],"date-time":"2016-07-01T00:00:00Z","timestamp":1467331200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,7,1]],"date-time":"2017-07-01T00:00:00Z","timestamp":1498867200000},"content-version":"vor","delay-in-days":365,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["jidonline.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Investigative Dermatology"],"published-print":{"date-parts":[[2016,7]]},"DOI":"10.1016\/j.jid.2016.02.811","type":"journal-article","created":{"date-parts":[[2016,3,16]],"date-time":"2016-03-16T18:24:42Z","timestamp":1458152682000},"page":"1346-1354","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":50,"title":["Gene-Corrected Fibroblast Therapy for Recessive Dystrophic Epidermolysis Bullosa using a Self-Inactivating COL7A1 Retroviral\u00a0Vector"],"prefix":"10.1016","volume":"136","author":[{"given":"Joanna","family":"Jack\u00f3w","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthias","family":"Titeux","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Soizic","family":"Portier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"So\u00ebli","family":"Charbonnier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clarisse","family":"Ganier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sonia","family":"Gaucher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alain","family":"Hovnanian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jid.2016.02.811_bib1","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1111\/ics.12064","article-title":"Comparison between fibroblasts and mesenchymal stem cells derived from dermal and adipose tissue","volume":"35","author":"Brohem","year":"2013","journal-title":"Int J Cosmet Sci"},{"key":"10.1016\/j.jid.2016.02.811_bib2","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1007\/s10875-010-9415-4","article-title":"Human fibroblasts share immunosuppressive properties with bone marrow mesenchymal stem cells","volume":"30","author":"Cappellesso-Fleury","year":"2010","journal-title":"J\u00a0Clin Immunol"},{"key":"10.1016\/j.jid.2016.02.811_bib3","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1038\/gt.2013.18","article-title":"Self-inactivating MLV vectors have a reduced genotoxic profile in human epidermal keratinocytes","volume":"20","author":"Cavazza","year":"2013","journal-title":"Gene Ther"},{"key":"10.1016\/j.jid.2016.02.811_bib4","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1038\/ng1041","article-title":"Restoration of type VII collagen expression and function in dystrophic epidermolysis bullosa","volume":"32","author":"Chen","year":"2002","journal-title":"Nat Genet"},{"key":"10.1016\/j.jid.2016.02.811_bib5","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.det.2009.10.011","article-title":"Type VII collagen: the anchoring fibril protein at fault in dystrophic epidermolysis bullosa","volume":"28","author":"Chung","year":"2010","journal-title":"Dermatol Clin"},{"key":"10.1016\/j.jid.2016.02.811_bib6","doi-asserted-by":"crossref","first-page":"429","DOI":"10.3109\/14653241003587637","article-title":"Replenishment of type VII collagen and re-epithelialization of chronically ulcerated skin after intradermal administration of allogeneic mesenchymal stromal cells in two patients with recessive dystrophic epidermolysis bullosa","volume":"12","author":"Conget","year":"2010","journal-title":"Cytotherapy"},{"key":"10.1016\/j.jid.2016.02.811_bib7","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1016\/0014-4827(73)90588-0","article-title":"Doubling potential, calendar time, and senescence of human diploid cells in culture","volume":"77","author":"Dell\u2019Orco","year":"1973","journal-title":"Exp Cell Res"},{"key":"10.1016\/j.jid.2016.02.811_bib8","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/0014-4827(74)90416-9","article-title":"Doubling potential, calendar time, and donor age of human diploid cells in culture","volume":"84","author":"Dell\u2019Orco","year":"1974","journal-title":"Exp Cell Res"},{"key":"10.1016\/j.jid.2016.02.811_bib9","doi-asserted-by":"crossref","first-page":"380","DOI":"10.15252\/emmm.201404353","article-title":"A\u00a0single epidermal stem cell strategy for safe ex\u00a0vivo gene therapy","volume":"7","author":"Droz-Georget Lathion","year":"2015","journal-title":"EMBO Mol Med"},{"key":"10.1016\/j.jid.2016.02.811_bib10","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1016\/j.jaad.2014.01.903","article-title":"Inherited epidermolysis bullosa: updated recommendations on diagnosis and classification","volume":"70","author":"Fine","year":"2014","journal-title":"J\u00a0Am Acad Dermatol"},{"key":"10.1016\/j.jid.2016.02.811_bib11","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/j.jaad.2009.03.052","article-title":"Extracutaneous manifestations and complications of inherited epidermolysis bullosa: part I. Epithelial associated tissues","volume":"61","author":"Fine","year":"2009","journal-title":"J\u00a0Am Acad Dermatol"},{"key":"10.1016\/j.jid.2016.02.811_bib12","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/j.jaad.2009.03.053","article-title":"Extracutaneous manifestations and complications of inherited epidermolysis bullosa: part II. Other organs","volume":"61","author":"Fine","year":"2009","journal-title":"J\u00a0Am Acad Dermatol"},{"key":"10.1016\/j.jid.2016.02.811_bib13","doi-asserted-by":"crossref","first-page":"30248","DOI":"10.1074\/jbc.M109.045294","article-title":"Dominant-negative effects of COL7A1 mutations can be rescued by controlled overexpression of normal collagen VII","volume":"284","author":"Fritsch","year":"2009","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.jid.2016.02.811_bib14","doi-asserted-by":"crossref","first-page":"14345","DOI":"10.1073\/pnas.1000044107","article-title":"Bone marrow transplantation restores epidermal basement membrane protein expression and rescues epidermolysis bullosa model mice","volume":"107","author":"Fujita","year":"2010","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.jid.2016.02.811_bib15","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1089\/hum.2004.15.921","article-title":"Construction of skin equivalents for gene therapy of recessive dystrophic epidermolysis bullosa","volume":"15","author":"Gache","year":"2004","journal-title":"Hum Gene Ther"},{"key":"10.1016\/j.jid.2016.02.811_bib16","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1038\/JID.2015.364","article-title":"Lentiviral engineered fibroblasts expressing codon optimized COL7A1 restore anchoring fibrils in RDEB","volume":"136","author":"Georgiadis","year":"2016","journal-title":"J\u00a0Invest Dermatol"},{"key":"10.1016\/j.jid.2016.02.811_bib17","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/0014-4827(74)90252-3","article-title":"Senescence of cultured human fibroblasts: mitotic versus metabolic time","volume":"88","author":"Goldstein","year":"1974","journal-title":"Exp Cell Res"},{"key":"10.1016\/j.jid.2016.02.811_bib18","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1111\/bjd.13737","article-title":"Characterization of dystrophic epidermolysis bullosa patients for collagen VII therapy","volume":"173","author":"Gorell","year":"2015","journal-title":"The Br J Dermatol"},{"key":"10.1016\/j.jid.2016.02.811_bib19","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1038\/sj.jid.5700117","article-title":"Fibroblasts show more potential as target cells than keratinocytes in COL7A1 gene therapy of dystrophic epidermolysis bullosa","volume":"126","author":"Goto","year":"2006","journal-title":"J\u00a0Invest Dermatol"},{"key":"10.1016\/j.jid.2016.02.811_bib20","first-page":"1465","article-title":"In situ detection of fragmented DNA (TUNEL assay) fails to discriminate among apoptosis, necrosis, and autolytic cell death: a cautionary note","volume":"21","author":"Grasl-Kraupp","year":"1995","journal-title":"Hepatology"},{"key":"10.1016\/j.jid.2016.02.811_bib21","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1111\/j.1742-481X.2012.00973.x","article-title":"Living in dressings and bandages: findings from workshops with people with Epidermolysis bullosa","volume":"10","author":"Grocott","year":"2013","journal-title":"Int Wound J"},{"key":"10.1016\/j.jid.2016.02.811_bib22","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1097\/SPC.0b013e32835c0482","article-title":"Malignant wound management in advanced illness: new insights","volume":"7","author":"Grocott","year":"2013","journal-title":"Curr Opin Support Palliat Care"},{"key":"10.1016\/j.jid.2016.02.811_bib23","doi-asserted-by":"crossref","first-page":"1595","DOI":"10.4049\/jimmunol.179.3.1595","article-title":"Adult human fibroblasts are potent immunoregulatory cells and functionally equivalent to mesenchymal stem cells","volume":"179","author":"Haniffa","year":"2007","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.jid.2016.02.811_bib24","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1111\/exd.12666","article-title":"Therapies for inherited skin fragility disorders","volume":"24","author":"Has","year":"2015","journal-title":"Exp Dermatol"},{"key":"10.1016\/j.jid.2016.02.811_bib25","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/0531-5565(68)90054-5","article-title":"The division potential of cells in continuous growth as compared to cells subcultivated after maintenance in stationary phase","volume":"3","author":"Hay","year":"1968","journal-title":"Exp Gerontol"},{"key":"10.1016\/j.jid.2016.02.811_bib26","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1089\/humc.2014.083","article-title":"HEK293-based production platform for gamma-retroviral (self-inactivating) vectors: application for safe and efficient transfer of COL7A1 cDNA","volume":"25","author":"Hennig","year":"2014","journal-title":"Hum Gene Ther Clin Dev"},{"key":"10.1016\/j.jid.2016.02.811_bib27","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.matbio.2015.05.006","article-title":"The extracellular matrix and transforming growth factor-beta1: Tale of a strained relationship","volume":"47","author":"Hinz","year":"2015","journal-title":"Matrix Biol"},{"key":"10.1016\/j.jid.2016.02.811_bib28","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1016\/S0140-6736(05)67107-3","article-title":"Tissue engineered fetal skin constructs for paediatric burns","volume":"366","author":"Hohlfeld","year":"2005","journal-title":"Lancet"},{"key":"10.1016\/j.jid.2016.02.811_bib29","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1086\/515495","article-title":"Characterization of 18 new mutations in COL7A1 in recessive dystrophic epidermolysis bullosa provides evidence for distinct molecular mechanisms underlying defective anchoring fibril formation","volume":"61","author":"Hovnanian","year":"1997","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.jid.2016.02.811_bib30","doi-asserted-by":"crossref","first-page":"1996","DOI":"10.4049\/jimmunol.1400914","article-title":"Transplanted bone marrow-derived circulating PDGFRalpha+ cells restore type VII collagen in recessive dystrophic epidermolysis bullosa mouse skin graft","volume":"194","author":"Iinuma","year":"2015","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.jid.2016.02.811_bib31","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1016\/j.jid.2015.10.060","article-title":"Generation of a functional non-shedding collagen XVII mouse model: Relevance of collagen XVII shedding in wound healing","volume":"136","author":"Jack\u00f3w","year":"2016","journal-title":"J\u00a0Invest Dermatol"},{"key":"10.1016\/j.jid.2016.02.811_bib32","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1038\/mt.2009.144","article-title":"Mechanisms of fibroblast cell therapy for dystrophic epidermolysis bullosa: high stability of collagen VII favors long-term skin integrity","volume":"17","author":"Kern","year":"2009","journal-title":"Mol Ther"},{"key":"10.1016\/j.jid.2016.02.811_bib33","doi-asserted-by":"crossref","first-page":"1368","DOI":"10.1038\/mt.2015.58","article-title":"High local concentrations of intradermal MSCs restore skin integrity and facilitate wound healing in dystrophic epidermolysis bullosa","volume":"23","author":"Kuhl","year":"2015","journal-title":"Mol Ther"},{"key":"10.1016\/j.jid.2016.02.811_bib34","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1038\/msb.2013.17","article-title":"Global remodelling of cellular microenvironment due to loss of collagen VII","volume":"9","author":"Kuttner","year":"2013","journal-title":"Mol Syst Biol"},{"key":"10.1016\/j.jid.2016.02.811_bib35","doi-asserted-by":"crossref","first-page":"e87263","DOI":"10.1371\/journal.pone.0087263","article-title":"Transmembrane collagen XVII modulates integrin dependent keratinocyte migration via PI3K\/Rac1 signaling","volume":"9","author":"Loffek","year":"2014","journal-title":"PloS One"},{"key":"10.1016\/j.jid.2016.02.811_bib36","doi-asserted-by":"crossref","first-page":"e114949","DOI":"10.1371\/journal.pone.0114949","article-title":"Negligible immunogenicity of induced pluripotent stem cells derived from human skin fibroblasts","volume":"9","author":"Lu","year":"2014","journal-title":"PloS One"},{"key":"10.1016\/j.jid.2016.02.811_bib37","doi-asserted-by":"crossref","first-page":"4133","DOI":"10.1096\/fj.09-151449","article-title":"Unique and redundant functions of integrins in the epidermis","volume":"24","author":"Margadant","year":"2010","journal-title":"FASEB J"},{"key":"10.1016\/j.jid.2016.02.811_bib38","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/0531-5565(71)90052-0","article-title":"Limited culture lifespan of human diploid cells as a function of metabolic time instead of division potential","volume":"6","author":"McHale","year":"1971","journal-title":"Exp Gerontol"},{"key":"10.1016\/j.jid.2016.02.811_bib39","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1172\/JCI37630","article-title":"The genotoxic potential of retroviral vectors is strongly modulated by vector design and integration site selection in a mouse model of HSC gene therapy","volume":"119","author":"Montini","year":"2009","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.jid.2016.02.811_bib40","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1038\/jid.2010.249","article-title":"Functional correction of type VII collagen expression in dystrophic epidermolysis bullosa","volume":"131","author":"Murauer","year":"2011","journal-title":"J\u00a0Invest Dermatol"},{"key":"10.1016\/j.jid.2016.02.811_bib41","doi-asserted-by":"crossref","first-page":"1771","DOI":"10.1038\/jid.2011.85","article-title":"HB-EGF induces COL7A1 expression in keratinocytes and fibroblasts: possible mechanism underlying allogeneic fibroblast therapy in recessive dystrophic epidermolysis Bullosa","volume":"131","author":"Nagy","year":"2011","journal-title":"J\u00a0Invest Dermatol"},{"key":"10.1016\/j.jid.2016.02.811_bib42","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1172\/JCI200317193","article-title":"Injection of genetically engineered fibroblasts corrects regenerated human epidermolysis bullosa skin tissue","volume":"111","author":"Ortiz-Urda","year":"2003","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.jid.2016.02.811_bib43","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1089\/104303403765701204","article-title":"PhiC31 integrase-mediated nonviral genetic correction of junctional epidermolysis bullosa","volume":"14","author":"Ortiz-Urda","year":"2003","journal-title":"Hum Gene Ther"},{"key":"10.1016\/j.jid.2016.02.811_bib44","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.1038\/nm766","article-title":"Stable nonviral genetic correction of inherited human skin disease","volume":"8","author":"Ortiz-Urda","year":"2002","journal-title":"Nat Med"},{"key":"10.1016\/j.jid.2016.02.811_bib45","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1038\/mt.2013.56","article-title":"TALEN-based gene correction for epidermolysis bullosa","volume":"21","author":"Osborn","year":"2013","journal-title":"Mol Ther"},{"key":"10.1016\/j.jid.2016.02.811_bib46","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1038\/gt.2010.36","article-title":"Immune reactivity to type VII collagen: implications for gene therapy of recessive dystrophic epidermolysis bullosa","volume":"17","author":"Pendaries","year":"2010","journal-title":"Gene Ther"},{"key":"10.1016\/j.jid.2016.02.811_bib47","doi-asserted-by":"crossref","first-page":"2319","DOI":"10.1038\/jid.2015.158","article-title":"Potential of Systemic Allogeneic Mesenchymal Stromal Cell Therapy for Children with Recessive Dystrophic Epidermolysis Bullosa","volume":"135","author":"Petrof","year":"2015","journal-title":"J\u00a0Invest Dermatol"},{"key":"10.1016\/j.jid.2016.02.811_bib48","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1111\/bjd.12599","article-title":"Fibroblast cell therapy enhances initial healing in recessive dystrophic epidermolysis bullosa wounds: results of a randomized, vehicle-controlled trial","volume":"169","author":"Petrof","year":"2013","journal-title":"Br J\u00a0Dermatol"},{"key":"10.1016\/j.jid.2016.02.811_bib49","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1038\/mt.2008.234","article-title":"Injection of recombinant human type VII collagen corrects the disease phenotype in a murine model of dystrophic epidermolysis bullosa","volume":"17","author":"Remington","year":"2009","journal-title":"Mol Ther"},{"key":"10.1016\/j.jid.2016.02.811_bib50","doi-asserted-by":"crossref","first-page":"49","DOI":"10.3109\/07853890.2013.866441","article-title":"Inherited blistering skin diseases: underlying molecular mechanisms and emerging therapies","volume":"46","author":"Salam","year":"2014","journal-title":"Ann Med"},{"key":"10.1016\/j.jid.2016.02.811_bib51","doi-asserted-by":"crossref","first-page":"264ra163","DOI":"10.1126\/scitranslmed.3009540","article-title":"Human COL7A1-corrected induced pluripotent stem cells for the treatment of recessive dystrophic epidermolysis bullosa","volume":"6","author":"Sebastiano","year":"2014","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.jid.2016.02.811_bib52","doi-asserted-by":"crossref","first-page":"6609","DOI":"10.1073\/pnas.1016753108","article-title":"PDGFRalpha-positive cells in bone marrow are mobilized by high mobility group box 1 (HMGB1) to regenerate injured epithelia","volume":"108","author":"Tamai","year":"2011","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.jid.2016.02.811_bib53","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.1038\/mt.2010.91","article-title":"SIN retroviral vectors expressing COL7A1 under human promoters for ex\u00a0vivo gene therapy of recessive dystrophic epidermolysis bullosa","volume":"18","author":"Titeux","year":"2010","journal-title":"Mol Ther"},{"key":"10.1016\/j.jid.2016.02.811_bib54","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1182\/blood-2008-06-161299","article-title":"Amelioration of epidermolysis bullosa by transfer of wild-type bone marrow cells","volume":"113","author":"Tolar","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.jid.2016.02.811_bib55","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1038\/jid.2010.346","article-title":"Induced pluripotent stem cells from individuals with recessive dystrophic epidermolysis bullosa","volume":"131","author":"Tolar","year":"2011","journal-title":"J\u00a0Invest Dermatol"},{"key":"10.1016\/j.jid.2016.02.811_bib56","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1002\/humu.21551","article-title":"The international dystrophic epidermolysis bullosa patient registry: an online database of dystrophic epidermolysis bullosa patients and their COL7A1 mutations","volume":"32","author":"van den Akker","year":"2011","journal-title":"Hum Mut"},{"key":"10.1016\/j.jid.2016.02.811_bib57","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1136\/jmg.2006.045302","article-title":"Epidermolysis bullosa. II. Type VII collagen mutations and phenotype-genotype correlations in the dystrophic subtypes","volume":"44","author":"Varki","year":"2007","journal-title":"J\u00a0Med Genet"},{"key":"10.1016\/j.jid.2016.02.811_bib58","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1016\/j.jaad.2013.08.014","article-title":"A\u00a0phase II randomized vehicle-controlled trial of intradermal allogeneic fibroblasts for recessive dystrophic epidermolysis bullosa","volume":"69","author":"Venugopal","year":"2013","journal-title":"J\u00a0Am Acad Dermatol"},{"key":"10.1016\/j.jid.2016.02.811_bib59","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1056\/NEJMoa0910501","article-title":"Bone marrow transplantation for recessive dystrophic epidermolysis bullosa","volume":"363","author":"Wagner","year":"2010","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jid.2016.02.811_bib60","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1038\/mt.2015.47","article-title":"From marrow to matrix: novel gene and cell therapies for epidermolysis bullosa","volume":"23","author":"Webber","year":"2015","journal-title":"Mol Ther"},{"key":"10.1016\/j.jid.2016.02.811_bib61","doi-asserted-by":"crossref","first-page":"264ra165","DOI":"10.1126\/scitranslmed.3010083","article-title":"Genetically corrected iPSCs as cell therapy for recessive dystrophic epidermolysis bullosa","volume":"6","author":"Wenzel","year":"2014","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.jid.2016.02.811_bib62","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1002\/humu.21651","article-title":"The COL7A1 mutation database","volume":"33","author":"Wertheim-Tysarowska","year":"2012","journal-title":"Hum Mut"},{"key":"10.1016\/j.jid.2016.02.811_bib63","doi-asserted-by":"crossref","first-page":"2179","DOI":"10.1038\/jid.2008.78","article-title":"Potential of fibroblast cell therapy for recessive dystrophic epidermolysis bullosa","volume":"128","author":"Wong","year":"2008","journal-title":"J\u00a0Invest Dermatol"},{"key":"10.1016\/j.jid.2016.02.811_bib64","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1038\/nm1063","article-title":"Injection of recombinant human type VII collagen restores collagen function in dystrophic epidermolysis bullosa","volume":"10","author":"Woodley","year":"2004","journal-title":"Nat Med"},{"key":"10.1016\/j.jid.2016.02.811_bib65","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1046\/j.1523-1747.2003.12571.x","article-title":"Normal and gene-corrected dystrophic epidermolysis bullosa fibroblasts alone can produce type VII collagen at the basement membrane zone","volume":"121","author":"Woodley","year":"2003","journal-title":"J\u00a0Invest Dermatol"},{"key":"10.1016\/j.jid.2016.02.811_bib66","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1038\/sj.mt.6300041","article-title":"Intravenously injected human fibroblasts home to skin wounds, deliver type VII collagen, and promote wound healing","volume":"15","author":"Woodley","year":"2007","journal-title":"Mol Ther"},{"key":"10.1016\/j.jid.2016.02.811_bib67","doi-asserted-by":"crossref","first-page":"1910","DOI":"10.1038\/jid.2013.10","article-title":"Intravenously injected recombinant human type VII collagen homes to skin wounds and restores skin integrity of dystrophic epidermolysis bullosa","volume":"133","author":"Woodley","year":"2013","journal-title":"J\u00a0Invest Dermatol"},{"key":"10.1016\/j.jid.2016.02.811_bib68","doi-asserted-by":"crossref","first-page":"e70408","DOI":"10.1371\/journal.pone.0070408","article-title":"Fetal fibroblasts and keratinocytes with immunosuppressive properties for allogeneic cell-based wound therapy","volume":"8","author":"Zuliani","year":"2013","journal-title":"PloS One"}],"container-title":["Journal of Investigative Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022202X16308740?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022202X16308740?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,11,22]],"date-time":"2018-11-22T23:54:12Z","timestamp":1542930852000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022202X16308740"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,7]]},"references-count":68,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2016,7]]}},"alternative-id":["S0022202X16308740"],"URL":"https:\/\/doi.org\/10.1016\/j.jid.2016.02.811","relation":{},"ISSN":["0022-202X"],"issn-type":[{"value":"0022-202X","type":"print"}],"subject":[],"published":{"date-parts":[[2016,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Gene-Corrected Fibroblast Therapy for Recessive Dystrophic Epidermolysis Bullosa using a Self-Inactivating COL7A1 Retroviral\u00a0Vector","name":"articletitle","label":"Article Title"},{"value":"Journal of Investigative Dermatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jid.2016.02.811","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 The Authors. Published by Elsevier, Inc. on behalf of the Society for Investigative Dermatology.","name":"copyright","label":"Copyright"}]}}